Zobrazeno 1 - 3
of 3
pro vyhledávání: '"George Teto"'
Autor:
Joseph Fokam, Collins Ambe Chenwi, Desire Takou, Maria Mercedes Santoro, Valere Tala, George Teto, Grace Beloumou, Ezechiel Ngoufack Jagni Semengue, Beatrice Dambaya, Sandrine Djupsa, Etienne Kembou, Nounouce Pamen Bouba, Rogers Ajeh, Giulia Cappelli, Dora Mbanya, Vittorio Colizzi, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Alexis Ndjolo
Publikováno v:
Viruses, Vol 15, Iss 8, p 1683 (2023)
Increased HIV drug resistance (HIVDR) with antiretroviral therapy (ART) rollout may jeopardize therapeutic options, especially in this era of transition to fixed-dose tenofovir-lamivudine-dolutegravir (TLD). We studied acquired HIVDR (ADR) patterns a
Externí odkaz:
https://doaj.org/article/fcb3b7323f5b4df2a72a4d13fe422025
Autor:
Joseph Fokam, Collins Ambe Chenwi, Valère Tala, Désiré Takou, Maria Mercedes Santoro, George Teto, Beatrice Dambaya, Felix Anubodem, Ezechiel Ngoufack Jagni Semengue, Grace Beloumou, Sandrine Djupsa, Edgar Assomo, Charles Fokunang, Claudia Alteri, Serge Billong, Nounouce Pamen Bouba, Rogers Ajeh, Vittorio Colizzi, Dora Mbanya, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Alexis Ndjolo
Publikováno v:
Viruses, Vol 15, Iss 7, p 1458 (2023)
The efficacy of first-line antiretroviral therapy (ART) may be hampered by the presence of HIV drug resistance (HIVDR). We described HIV-1 pre-treatment drug resistance (PDR) patterns, effect of viral clades on PDR, and programmatic implications on f
Externí odkaz:
https://doaj.org/article/a4c3ba70cbd24cff805986f1453be787
Autor:
Ndjolo, Joseph Fokam, Collins Ambe Chenwi, Valère Tala, Désiré Takou, Maria Mercedes Santoro, George Teto, Beatrice Dambaya, Felix Anubodem, Ezechiel Ngoufack Jagni Semengue, Grace Beloumou, Sandrine Djupsa, Edgar Assomo, Charles Fokunang, Claudia Alteri, Serge Billong, Nounouce Pamen Bouba, Rogers Ajeh, Vittorio Colizzi, Dora Mbanya, Francesca Ceccherini-Silberstein, Carlo-Federico Perno, Alexis
Publikováno v:
Viruses; Volume 15; Issue 7; Pages: 1458
The efficacy of first-line antiretroviral therapy (ART) may be hampered by the presence of HIV drug resistance (HIVDR). We described HIV-1 pre-treatment drug resistance (PDR) patterns, effect of viral clades on PDR, and programmatic implications on f